December 05, 2016 12:05 PM ET

Pharmaceuticals

Company Overview of Prexton Therapeutics SA

Company Overview

Prexton Therapeutics SA develops Parkinson’s drugs that target the metabotropic glutamate receptors mGluR3 and mGluR4. The company was founded in 2012 and is based in Geneva, Switzerland.

Chemin des Aulx 14

Plan-les-Ouates

Geneva,  1228

Switzerland

Founded in 2012

Key Executives for Prexton Therapeutics SA

Founder and Chief Executive Officer
Compensation as of Fiscal Year 2016.

Prexton Therapeutics SA Key Developments

Prexton Therapeutics SA Presents at 16th Annual Biotech in Europe Forum, Sep-27-2016 02:45 PM

Prexton Therapeutics SA Presents at 16th Annual Biotech in Europe Forum, Sep-27-2016 02:45 PM. Venue: MCH Messe Schweiz (Basel) AG, Messepl. 21, CH-4058 Basel, Switzerland. Speakers: Francois Conquet, CEO.

Prexton Therapeutics SA Presents at BioEquity Europe 2016 Conference, May-10-2016

Prexton Therapeutics SA Presents at BioEquity Europe 2016 Conference, May-10-2016 . Venue: Scandic Hotel, Vester Soegade 6, 1601 Copenhagen, Denmark.

Prexton Therapeutics SA Presents at BioEquity Europe 2015, May-19-2015 02:00 PM

Prexton Therapeutics SA Presents at BioEquity Europe 2015, May-19-2015 02:00 PM. Venue: InterContinental Vienna, Vienna, Austria.

Similar Private Companies By Industry

Company Name Region
Acino International AG Europe
Activen SA Europe
Albea Pharmaceuticals AG Europe
Alpen Pharma AG Europe
Alpex Pharma SA Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Prexton Therapeutics SA, please visit www.prextontherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.